Area of research
Cell Biology · Pathology and Forensic Medicine
Research interest
Research focused on Postprandial and Strain (injury), with related work in Kaempferol, CD8, Immune system. Notable publications include 'Dorzagliatin (HMS5552), a novel dual‐acting glucokinase activator, improves glycaemic control and pancreatic β‐cell function in patients with type 2 diabetes: A 28‐day treatment...', 'Characterization of the strain-rate–dependent mechanical response of single cell–cell junctions', and 'Kaempferol Promotes Transplant Tolerance by Sustaining CD4+FoxP3+ Regulatory T Cells in the Presence of Calcineurin Inhibitor'.
Characterization of the strain-rate–dependent mechanical response of single cell–cell junctions
Dorzagliatin (HMS5552), a novel dual‐acting glucokinase activator, improves glycaemic control and pancreatic β‐cell function in patients with type 2 diabetes: A 28‐day treatment study using biomarker‐guided patient selection
Herbal Components of a Novel Formula PSORI-CM02 Interdependently Suppress Allograft Rejection and Induce CD8+CD122+PD-1+ Regulatory T Cells
Medicinal herbs<i>Fructus corni</i>and<i>Semen cuscutae</i>suppress allograft rejection<i>via</i>distinct immune mechanisms
Kaempferol Promotes Transplant Tolerance by Sustaining CD4+FoxP3+ Regulatory T Cells in the Presence of Calcineurin Inhibitor